17.16

2.22% -0.39

Centessa Pharmaceuticals Plc Adr (CNTA)

Overview News Price History Option Chain Financials Discussions Forecast

Centessa Pharmaceuticals Plc Adr stock is traded at $17.16, with a volume of 774.78K. It is down -2.22% in the last 24 hours and up +2.51% over the past month. Centessa Pharmaceuticals PLC is a clinical-stage pharmaceutical company. The company's pipeline assets include 1) SerpinPC for Hemophilia A, B, 2) LB101 for Solid Tumors, 3) ORX750 for Narcolepsy Type 1 (NT1) and other sleep disorders, 4) MGX292 Pulmonary Arterial Hypertension (PAH) and 5) Undisclosed for Solid Tumors.

Previous Close:

$17.55

Open:

$17.55

24h Volume:

774.78K

Relative Volume:

1.41

Market Cap:

$2.26B

Revenue:

Net Income/Loss:

$-151.09M

P/E Ratio:

-9.4807

EPS:

-1.81

Net Cash Flow:

$-160.51M

1W Performance:

+3.56%

1M Performance:

+2.51%

6M Performance:

+93.68%

1Y Performance:

+130.96%

1-Day Range:

$16.94

$17.94

1-Week Range:

$15.88

$18.12

52-Week Range:

$6.65

$18.97

Centessa Pharmaceuticals Plc Adr Stock (CNTA) Company Profile

Name

Centessa Pharmaceuticals Plc Adr

Sector

Healthcare (1176)

Industry

Biotechnology (673)

Phone

44 7391 789784

Address

3RD FLOOR, ALTRINCHAM, CHESHIRE

Employee

Twitter

Next Earnings Date

Latest SEC Filings

CNTA's Discussions on Twitter

Compare CNTA with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
CNTA Centessa Pharmaceuticals Plc Adr	17.16	2.26B	0	-151.09M	-160.51M	-1.56
VRTX Vertex Pharmaceuticals Inc	397.27	102.31B	10.63B	-479.80M	-1.35B	-1.99
REGN Regeneron Pharmaceuticals Inc	701.85	77.13B	13.85B	4.65B	3.32B	40.41
ARGX Argen X Se Adr	623.82	37.30B	1.86B	-40.29M	-1.28B	-0.85
ALNY Alnylam Pharmaceuticals Inc	245.44	31.66B	2.09B	-332.26M	16.06M	-2.62
BNTX Biontech Se Adr	113.08	27.11B	3.30B	-501.07M	1.03B	-2.1146

Centessa Pharmaceuticals Plc Adr Stock (CNTA) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Sep-20-24	Upgrade	Morgan Stanley	Equal-Weight → Overweight
Sep-19-24	Initiated	B. Riley Securities	Buy
Jul-18-24	Initiated	Oppenheimer	Outperform
Nov-15-23	Upgrade	Jefferies	Hold → Buy
Oct-26-23	Upgrade	Morgan Stanley	Underweight → Equal-Weight
Jun-21-23	Initiated	Evercore ISI	Outperform
Jun-12-23	Initiated	Guggenheim	Buy
Mar-17-23	Initiated	SVB Securities	Outperform
Aug-12-22	Downgrade	Morgan Stanley	Overweight → Underweight
Jun-17-22	Initiated	BMO Capital Markets	Outperform
Jun-03-22	Downgrade	Jefferies	Buy → Hold
Feb-11-22	Initiated	Goldman	Neutral

View All

Centessa Pharmaceuticals Plc Adr Stock (CNTA) Latest News

Dec 20, 2024

Centessa Pharmaceuticals CEO sells $959,057 in shares - Investing.com

Dec 20, 2024

Dec 17, 2024

Centessa Pharmaceuticals general counsel sells shares for $1.27 million - Investing.com

Dec 17, 2024

Stock Market Recap: Tencent Music Entertainment Group ADR (TME) Concludes at 11.30, a -5.68 Surge/Decline - The Dwinnex

Dec 17, 2024

Dec 12, 2024

Banzai International Inc (NASDAQ: BNZI): Getting A Free Pass? - Stocks Register

Dec 12, 2024

Metrics That Matter About Credo Technology Group Holding Ltd (NASDAQ: CRDO) - Stocks Register

Dec 12, 2024

Dec 06, 2024

Centessa Pharmaceuticals stock hits 52-week high at $18.77 By Investing.com - Investing.com UK

Dec 06, 2024

Nov 27, 2024

Centessa Pharmaceuticals CEO Saha Saurabh sells $5,450 in shares - Investing.com India

Nov 27, 2024

Centessa Pharmaceuticals' chief business officer sells $176,601 in shares - Investing.com

Nov 27, 2024

Nov 23, 2024

Centessa Pharmaceuticals CEO Saurabh sells shares worth $1.02 million - Investing.com India

Nov 23, 2024

Nov 22, 2024

Centessa Pharmaceuticals CEO Saurabh sells shares worth $1.02 million By Investing.com - Investing.com South Africa

Nov 22, 2024

Nov 19, 2024

Deutsche Bank initates Fidelity National Financial Inc (FNF) stock to a Hold - Knox Daily

Nov 19, 2024

Nov 16, 2024

Centessa Pharmaceuticals CEO sells shares worth $585,418 - Investing.com India

Nov 16, 2024

Nov 12, 2024

Centessa Pharmaceuticals Reports Financial Results for the Third Quarter of 2024 and Provides Business Update - GlobeNewswire Inc.

Nov 12, 2024

Endava PLC Sponsored ADR (DAVA) Beats Q1 Earnings Estimates - Yahoo Finance

Nov 12, 2024

Oct 31, 2024

XPeng Inc. Sponsored ADR (XPEV) Stock Moves -1.06%: What You Should Know - Yahoo Finance

Oct 31, 2024

Oct 25, 2024

Centessa Pharmaceuticals' chief business officer sells shares for $180,628 - Investing.com

Oct 25, 2024

Zai Lab Limited (ZLAB) Moves 14.7% Higher: Will This Strength Last? - Yahoo Finance

Oct 25, 2024

Oct 24, 2024